On Tuesday, October 6, 2026, the UK government said it will accept all 44 recommendations from the National Commission into the Regulation of AI in Healthcare. The Commission, convened by the Medicines and Healthcare products Regulatory Agency (MHRA) and chaired by Professor Alastair Denniston, published its report on September 10 after a year of evidence work. Health Innovation Minister James Frith signed the ministerial foreword. The same day, MHRA opened applications for the third phase of AI Airlock, its regulatory sandbox for AI-enabled medical devices.

GOV.UK posted the news release and the full government response. Airlock Phase 3 is live for developers now. This is London paper, not a Truth Social roster and not a General Services Administration clause. (GOV.UK news; government response; Airlock Phase 3)

Phase 3 puts post-market surveillance and lifecycle oversight at the center. MHRA wants projects that watch AI devices after they ship, including deployment context, uneven local clinical oversight, and how safety information moves across the system. The call stays open year-round. Teams that want the current review wave should apply before October 31. A webinar for applicants is set for October 22. First-wave selection sits in November.

There is no application fee. Candidates still fund their own testing. The phase is funded through April 2029. Simulation, virtual, and real-world airlock environments are on the menu. (Airlock Phase 3; GOV.UK news)

The response also sets clocks boards can calendar. MHRA intends to issue draft guidance on Predetermined Change Control Plans by December 2026, so adaptive devices can change inside defined boundaries instead of a fresh clearance for every tweak. A consultation on how to qualify and classify AI-enabled devices is due by Spring 2027. That is recommendation one.

A cross-system Programme Board will meet quarterly. A full implementation roadmap covering all 44 recommendations is promised by Spring 2027, with annual progress updates after that. Tuesday's Force still has a secondary-reported 120-day clock. London printed its own. (government response; The Force)

Keep the Airlock in its lane. It is not Tuesday's Super Intelligence Force on Truth Social. It is not Sunday's General Services Administration clause 552.239-7001. It is not Friday's Federal Trade Commission consumer-risk file. It is UK medical-device policy accepting a doctors-led Commission and opening a sandbox that tests how AI tools behave after they leave the lab.

If someone tells the board that Washington's Force already answered UK market entry, ask for the sentence. Vendors selling diagnostics, ambient scribes, or decision support into the National Health Service now have an October 31 application date and a December change-control draft on the same sheet. (Airlock Phase 3; The Force; The Clause)

Tuesday already put The Force on the desk, now sent: the Super Intelligence Force announced on Truth Social, with Director of National Intelligence Jay Clayton in the chair. Monday's The Vision stays sent: the Kyoto Vision for a Golden Age of Science. Sunday's The Clause stays sent: General Services Administration clause 552.239-7001. Saturday's The Subpoena stays sent: California Attorney General Rob Bonta's investigative subpoena on OpenAI. Friday's The Probe stays sent: the Federal Trade Commission consumer-risk investigation into OpenAI, Anthropic, and other frontier labs. Thursday's The Accord stays sent: the White House Joint Commitment and the Super Intelligence rename order.

Wednesday's Florida's Hold stays sent. Tuesday's The AGs' Ask stays sent. Monday's Oregon's Frontier Buy stays sent. Sunday's Supply Chain Risk stays sent. Saturday's Agents That Probe stays sent. Friday's Virginia Executive Order 22 stays sent. California's Executive Order N-9-26 stays. The Cybersecurity and Infrastructure Security Agency and National Institute of Standards and Technology Interagency Report 8587 token guide stays put. Today's file is the Airlock. (The Force; The Vision; The Clause; The Subpoena; The Probe; The Accord)

Thursday's Agencia Española de Protección de Datos (AEPD) agent breach notice, Wednesday's Korea Internet & Security Agency (KISA) guide, Tuesday's Altman monitorability wall and multi-lab pact, and Monday's Amodei evaluator desks stay on the desk.

They already had their mornings. Madrid, Seoul, the older pact track, and permanent reviewers next to today's Airlock. (AEPD; SEDaily; TechTimes; Amodei)

Before a lab partner or a reseller treats Tuesday's Force and Tuesday's UK response as the same kind of paper, put three blanks on one page. Who owns the Airlock answer if a vendor cites Clayton's group to claim UK medical-device rules will stay light, or will harden. Who signs if someone says Phase 3 changed clause 552.239-7001, when the London text never touches that General Services Administration term. What you tell the board if the October 31 wave and the December Predetermined Change Control Plan draft are live while Saturday's California subpoena and Friday's Federal Trade Commission file still run their own clocks.

Write the questionnaire now. Put the same blanks next to every vendor who will treat a UK sandbox like optional reading. (Airlock Phase 3; The Force; The Probe)

The Move

London accepted all 44 healthcare-AI recommendations on Tuesday and opened Airlock Phase 3 the same morning. Not a statute from Congress. Not a Truth Social roster. A medical-device sandbox with an October 31 wave date and a December change-control draft.

Send counsel and the UK market lead a one-pager. Ask who owns the Airlock answer today, which products sit inside MHRA medical-device scope, and which buys are still governed by Sunday's GSA clause instead.

If the answer is "we do not sell into the National Health Service," the blank still goes next to every vendor who will treat Phase 3 like a press release.

Seven bullets. One move.